Pathway:Periplasmic NAD degradation
From Metabolomics.JP
(Difference between revisions)
(New page: {{Pathway/Metabolic | source = BMCCPUAPt031 |list= && BMCCPUAPt031$BMCCPUAP0021$0 && BMCCPUAP0021$BMCCPUAD0008$0 }}) |
(New page: {{Pathway/Metabolic | source = BMCCPUAPt031 |list= && BMCCPUAPt031$BMCCPUAP0021$0 && BMCCPUAP0021$BMCCPUAD0008$0 }}) |
||
| Line 1: | Line 1: | ||
| + | {{Pathway/Header}} | ||
| + | |||
{{Pathway/Metabolic | {{Pathway/Metabolic | ||
| source = BMCCPUAPt031 | | source = BMCCPUAPt031 | ||
Revision as of 19:00, 17 June 2009
| Basic Metabolism Top (代謝トップ) |
Molecule Index (化合物索引) |
EC classes ( EC分類) |
Pathways (代謝経路) |
Total 0 steps.
| NAD+ | |||||
|---|---|---|---|---|---|
|
| Mapping |  |
1→1; 2→2; 3→3; 4→4; 5→5; 6→6; 7→7; 8→8; 9→9; 10→10; 11→11; 12→12; 13→13; 14→14; 15→15; |
| Mapping | |
1→1; 3→3; 2→2; 5→5; 4→4; 7→7; 6→6; 9→9; 8→8; 15→15; 14→14; 13→13; 12→12; 11→11; 10→10; |
| 2- (6-Aminopurin-9-yl) -5- (hydroxymethyl) oxolane-3,4-diol | ||
|---|---|---|
 |
Trace 1 Trace 3 Trace 2 Trace 5 Trace 4 Trace 7 Trace 6 Trace 9 Trace 8 Trace 15 Trace 14 Trace 13 Trace 12 Trace 11 Trace 10
|
